Single-use Bioreactors Market: Growth, Size, Share, and Trends

Single-use Bioreactors Market by Product (Systems, Bags, Assemblies), Type (Stirred Tank, Bubble-Column, Wave induced), Molecule (mAbs, Vaccines), Cell Type (Mammalian, Bacterial, Yeast), Application (R&D, Bioproduction) - Global Forecast to 2029

Report Code: BT 2863 Aug, 2024, by marketsandmarkets.com

Market Growth Outlook Summary

The single-use bioreactors market growth forecasted to transform from $4.4 billion in 2024 to $9.1 billion by 2029, driven by a CAGR of 15.4%. The market is driven by the adoption of single-use technologies among CDMOs, CMOs, and SMEs, as well as the advantages of these systems over traditional stainless-steel bioreactors, including reduced capital investment and lower resource consumption. However, challenges such as leachables and extractables, regulatory barriers, and potential breakage of single-use bags may impede growth. Opportunities lie in the development of hybrid facilities combining single-use and stainless-steel systems. North America currently leads the market, with major players including Sartorius AG, Danaher Corporation, and Thermo Fisher Scientific Inc.

Single Use Bioreactors Market Trends

Single-Use Bioreactors Market

To know about the assumptions considered for the study, Request for Free Sample Report

Attractive Opportunities in the Single-use bioreactors Market

Single-Use Bioreactors Market

Single Use Bioreactors Market Dynamics

DRIVER: Growing adoption among CDMOs, CMOs, and SMEs

The SUBs market has experienced substantial growth as a result of the growing demand from contract development and manufacturing organizations (CDMOs) and contract manufacturing organizations (CMOs). By providing specialized services to companies seeking to outsource their pharmaceutical research and manufacturing processes, these companies are essential in the biopharmaceutical sector. Often handling several products and projects with different scales and needs, CDMOs and CMOs Single-use systems let them quickly transition between several processes without requiring the significant cleaning and validation processes associated with stainless-steel equipment. The initial investment for a single-use system, which includes capital, cleansing processes, labor, and waste, is nearly 42% lower than that of conventional stainless-steel systems. Small companies are thus also adopting SUBs increasingly to produce biopharmaceuticals since they are usually more affordable for small-scale operations.

RESTRAINT: Regulatory hurdles and compliance issues

Globally, regulatory authorities set strict criteria to guarantee the quality, efficacy, and safety of pharmaceuticals. Approval of the market, product commercialization, and continuous manufacturing activities depend on following these standards. One of the difficulties, however, is that single-use technologies and their application in biologic manufacturing are not specifically governed. In SUBs, end products are almost always made on a small scale. When these end products are scaled up to a larger scale, they must adhere to GMP safety, efficiency, and effectiveness standards. A major concern regarding the use of SUBs during the scale-up or scale-down process is that the molecules do not give the same results as they do in clinical trials. Additionally, concerns raised due to the mixing principle of SUBs have also increased the stringency of regulations and restricted their use.

OPPORTUNITY: Hybrid facilities

The hybrid facilities incorporating stainless steel and single-use systems represent a substantial opportunity within the SUBs market. Many companies use a hybrid approach, which includes some components of the process using single-use technologies, while others use traditional reusable, permanently plumbed systems. The pharmaceutical industry constantly experiences significant time and cost pressures. To respond to new developments in the sector as quickly as possible, the focus is increasingly centered on time-to-market and modular, highly flexible production models for novel biopharmaceutical products. The key benefits of hybrid facilities include lower costs, smaller footprints, and less support infrastructure, with some reusable equipment. Thus, an overall decrease in capital investment and increased flexibility associated with single-use systems result in their increased use by CDMOs and their clients.

CHALLENGE: Potential breakage of SU bags

The SU bags are extensively employed in a variety of bioprocessing stages, including media preparation, cell culture, storage, and transport, and are constructed from multi-layered plastic films. Their vulnerability to physical injury presents substantial hazards, such as operational disruptions, contamination, and product loss. The average cost of a single bag breaking was estimated to be between USD 100 and USD 1 million. One of the top three constraints that impede the further implementation of single-use technologies in biopharmaceutical processes, as identified by BioProcess International, is leakage. It has resulted in annual product losses of millions of dollars for certain biopharmaceutical manufacturers. Leaks can disrupt production and planning, result in product shortages, and pose a risk to operators, particularly when managing hazardous products like viruses or antibody-drug conjugates (ADCs). The Bio-Process Systems Alliance (BPSA) established a work group to establish best practices for assuring the integrity of single-use systems (SUS). This was done in response to concerns regarding the integrity of SUS.

Global Single Uuse bioreactors Ecosystem Analysis

The SUBs market operates within a complex ecosystem that includes a wide array of stakeholders, each playing a crucial role in developing, adopting, and implementing single-use technologies. This ecosystem encompasses single-use system & consumable manufacturers, biopharmaceutical companies, CMOs, CROs, and regulatory bodies.

Single-Use Bioreactors Market Ecosystem

The single-use bioreactor systems segment dominated single use bioreactors industry in 2023.

Based on products, the single use bioreactors market is segmented into single-use bioreactor systems, single-use media bags, single-use assemblies, and other products (including single-use vessels, sensors, tubing, connectors, software, control systems, and probes, among others). In 2023, the single-use bioreactor systems segment dominated the market. One of the biggest advantages of single-use bioreactor systems is their flexibility. The increasing focus of the biopharmaceutical industry on the production of multiple drugs simultaneously demands the production of different drugs using the same facility, with minimum time and cost and without compromising the quality of the drug. Players in the biopharmaceutical industry are increasingly adopting single-use systems due to their numerous advantages.

The stirred-tank single-use bioreactors segment dominated the single-use bioreactors industry in 2023.

Based on the type of single-use bioreactor systems, the single use bioreactors market is segmented into stirred-tank, wave-induced, bubble-column, and other single-use bioreactors (including hybrid bioreactors and SUBs with vertically perforated discs). The stirred-tank single-use bioreactors segment accounted for the largest share of the single-use bioreactors market in 2023. Stirred-tank bioreactors are the most common type of single-use bioreactors. Stirred-tank single-use bioreactors promote greater oxygen transfer than wave-induced single-use bioreactors. Hence, they are preferred to cultivate aerobic microbial cultures. The aeration and mixing in bioreactors are ensured by an aeration device, a static and rotating stirrer installed in the bag, resulting in high oxygen transfer rates and short mixing times.

North America was the largest regional market for the single use bioreactors industry in 2023.

Single-Use Bioreactors Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The global single use bioreactors market is segmented into six major regions—North America, Europe, the Asia Pacific, Latin America, Middle East and Africa. North America was the largest segment in 2023 in the single-use bioreactors market, followed by Europe and the Asia Pacific. Factors such as the presence of key biopharmaceutical research and development facilities in the region, rising demand for key biopharmaceutical products including monoclonal antibodies, vaccines, gene therapies, and cell therapies, among others are responsible for the largest share of this segment.

Key players in the single use bioreactors market include Sartorius AG (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Avantor, Inc. (US), Repligen Corporation (US), Getinge AB (Sweden), Eppendorf SE (Germany), Parker Hannifin Corporation (US), Entegris (US), Saint-Gobain (France), Corning Incorporated (US), Lonza (Switzerland), TECNIC Bioprocess Equipment Manufacturing (Spain), FUJIMORI KOGYO CO., LTD. (Japan), Kühner AG (Switzerland), OmniBRx Biotechnologies (India), New Horizon Biotechnology, Inc. (US), PBS Biotech, Inc. (US), bbi-biotech GmbH (Germany), ABEC, Inc. (US), Esco Lifesciences Group Ltd. (US), Distek, Inc. (US), SATAKE MultiMix Corporation (Japan), Cell Culture Company, LLC (US), Micro Digital Co., Ltd. (South Korea), Celltainer Biotech B.V. (Netherlands), Meissner Filtration Products, Inc. (US), Solida Biotech GmbH (Germany), G&G Technologies, Inc. (US), PharmNXT Biotech (India), and Tofflon Life Science Co., Ltd. (China).

Scope of the Single Use Bioreactors Industry:

Report Metric

Details

Market Revenue in 2024

$4.4 billion

Projected Revenue by 2029

$9.1 billion

Revenue Rate

Poised to Grow at a CAGR of 15.4%

Market Driver

Growing adoption among CDMOs, CMOs, and SMEs

Market Opportunity

Hybrid facilities

This report categorizes the single use bioreactors market to forecast revenue and analyze trends in each of the following submarkets:

By Product
  • Single-use Bioreactor Systems
    • ≤10 L
    • 11–100 L
    • 101–500 L
    • 501–1,500 L
    • >1,500 L
  • Single-use Media Bags
    • 2D Single-use Media Bags
    • 3D Single-use Media Bags 
    • Other Single-use Media bags
  • Single-use Assemblies
  • Other Products  
By Type
  • Stirred-Tank Single-use Bioreactors
  • Wave-Induced Single-use Bioreactors
  • Bubble-Column Single-use Bioreactors
  • Other Single-use Bioreactors
By Molecule Type
  • Monoclonal Antibodies
  • Vaccines
  • Therapeutic Proteins & Peptides
  • Stem Cells
  • Cell & Gene Therapy
By Cell Type
  • Mammalian Cells
  • Bacterial Cells
  • Yeast Cells
  • Other Cells
By Application
  • Bioproduction
  • Process Development
  • Research & Development
By End User
  • Pharmaceutical & Biotechnology Companies
  • CMOs & CROs
  • Academic & Research Institutes
By Region
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific (APAC)
    • China
    • South Korea
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • RoLATAM
  • Middle East
    • GCC
      • Saudi Arabia
      • UAE
      • Rest of GCC
    • Rest of Middle East
  • Africa

Recent Developments of Single Use Bioreactors Industry:

  • In March 2024, Getinge AB launched the Single-Use Production Reactor (SUPR) system, available in 50-liter and 250-liter sizes.
  • In April 2023, Merck KGaA launched the Ultimus single-use process container film designed to provide extreme durability and leak resistance for single-use assemblies used for bioprocessing liquid applications.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 39)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED
           1.3.3 CURRENCY CONSIDERED
    1.4 STAKEHOLDERS 
    1.5 SUMMARY OF CHANGES 
 
2 RESEARCH METHODOLOGY (Page No. - 44)
    2.1 RESEARCH DATA 
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
    2.2 MARKET ESTIMATION METHODOLOGY 
           2.2.1 MARKET ESTIMATION
           2.2.2 INSIGHTS FROM PRIMARY EXPERTS
           2.2.3 TOP-DOWN APPROACH
    2.3 MARKET GROWTH RATE PROJECTIONS 
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 
    2.5 RESEARCH ASSUMPTIONS 
    2.6 RESEARCH LIMITATIONS 
    2.7 RISK ANALYSIS 
    2.8 GENERATIVE AI IMPACT ON SINGLE USE BIOREACTORS MARKET 
 
3 EXECUTIVE SUMMARY (Page No. - 57)
 
4 PREMIUM INSIGHTS (Page No. - 62)
    4.1 SINGLE USE BIOREACTORS MARKET OVERVIEW 
    4.2 NORTH AMERICA: SINGLE USE BIOREACTORS INDUSTRY, BY APPLICATION AND COUNTRY (2023) 
    4.3 MARKET, BY END USER, 2024 VS. 2029 
    4.4 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
 
5 MARKET OVERVIEW (Page No. - 65)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
           5.2.1 DRIVERS
                    5.2.1.1 Growing adoption among CDMOs, CMOs, and SMEs
                    5.2.1.2 Advantages over conventional bioreactors
                    5.2.1.3 Reduced capital investment
                    5.2.1.4 Reduced water and energy consumption
                    5.2.1.5 Growing biologics & biosimilars markets
           5.2.2 RESTRAINTS
                    5.2.2.1 Issues related to extractables & leachables
                    5.2.2.2 Regulatory hurdles and compliance issues
                    5.2.2.3 Impact of PFAS restrictions on product development
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Untapped market potential in emerging economies
                    5.2.3.2 Hybrid facilities
           5.2.4 CHALLENGES
                    5.2.4.1 Lack of standardization
                    5.2.4.2 Waste disposal
                    5.2.4.3 Potential breakage of SU bags
    5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
    5.4 PRICING ANALYSIS 
           5.4.1 INDICATIVE PRODUCT PRICING ANALYSIS, BY KEY PLAYER, 2023
           5.4.2 INDICATIVE PRODUCT PRICING ANALYSIS, BY REGION, 2023
    5.5 SUPPLY CHAIN ANALYSIS 
    5.6 VALUE CHAIN ANALYSIS 
    5.7 ECOSYSTEM ANALYSIS 
           5.7.1 SINGLE USE BIOREACTORS MARKET: RAW MATERIAL SUPPLIERS
           5.7.2 SINGLE USE BIOREACTORS INDUSTRY: MANUFACTURERS
           5.7.3 MARKET: END USERS
           5.7.4 MARKET: REGULATORY BODIES
    5.8 TECHNOLOGY ANALYSIS 
           5.8.1 KEY TECHNOLOGIES
                    5.8.1.1 Fermentation
                    5.8.1.2 Continuous bioprocessing
                    5.8.1.3 3D cell culture
           5.8.2 COMPLEMENTARY TECHNOLOGIES
           5.8.3 ADJACENT TECHNOLOGIES
    5.9 PATENT ANALYSIS 
    5.10 KEY CONFERENCES AND EVENTS IN 2024–2025 
    5.11 REGULATORY LANDSCAPE 
           5.11.1 REGULATORY SCENARIO
                    5.11.1.1 North America
                               5.11.1.1.1 US
                               5.11.1.1.2 Canada
                    5.11.1.2 Europe
                               5.11.1.2.1 Germany
                               5.11.1.2.2 UK
                    5.11.1.3 Asia Pacific
                               5.11.1.3.1 Japan
                               5.11.1.3.2 China
                    5.11.1.4 Latin America
                               5.11.1.4.1 Brazil
           5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.12 INVESTMENT & FUNDING SCENARIO 
    5.13 PORTER’S FIVE FORCES ANALYSIS 
           5.13.1 THREAT OF NEW ENTRANTS
           5.13.2 THREAT OF SUBSTITUTES
           5.13.3 BARGAINING POWER OF BUYERS
           5.13.4 BARGAINING POWER OF SUPPLIERS
           5.13.5 INTENSITY OF COMPETITIVE RIVALRY
    5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
           5.14.2 BUYING CRITERIA FOR END USERS
    5.15 TRADE ANALYSIS 
    5.16 IMPACT OF GENERATIVE AI ON MARKET 
 
6 SINGLE USE BIOREACTORS MARKET, BY PRODUCT (Page No. - 106)
    6.1 INTRODUCTION 
    6.2 SINGLE-USE BIOREACTOR SYSTEMS 
           6.2.1 ≤10 L BIOREACTORS
                    6.2.1.1 Flexibility in early-stage R&D to boost market
           6.2.2 11–100 L BIOREACTORS
                    6.2.2.1 Scalability for process development to drive demand
           6.2.3 101–500 L BIOREACTORS
                    6.2.3.1 Efficiency in pilot-scale production to propel demand
           6.2.4 501–1500 L BIOREACTORS
                    6.2.4.1 Growing use in large-scale commercial production to drive market
           6.2.5 >1500 L BIOREACTORS
                    6.2.5.1 Rising adoption of single-use technologies in high-demand applications to support market growth
    6.3 SINGLE-USE MEDIA BAGS 
           6.3.1 2D SINGLE-USE MEDIA BAGS
                    6.3.1.1 Wide use of 2D bags in cell culture applications to drive market growth
           6.3.2 3D SINGLE-USE MEDIA BAGS
                    6.3.2.1 Usage in large-volume applications to drive market growth
           6.3.3 OTHER SINGLE-USE MEDIA BAGS
    6.4 SINGLE-USE ASSEMBLIES 
           6.4.1 OPERATIONAL EFFICIENCY AND FLEXIBILITY TO PROPEL DEMAND FOR SINGLE-USE ASSEMBLIES
    6.5 OTHER PRODUCTS 
 
7 SINGLE USE BIOREACTORS MARKET, BY TYPE (Page No. - 147)
    7.1 INTRODUCTION 
    7.2 STIRRED-TANK SINGLE-USE BIOREACTORS 
           7.2.1 GROWING PREFERENCE FOR AEROBIC MICROBIAL CELL CULTURES TO SUPPORT MARKET GROWTH
    7.3 WAVE-INDUCED SINGLE-USE BIOREACTORS 
           7.3.1 GROWING ADOPTION FOR SHEAR STRESS-SENSITIVE CELL LINES TO FUEL GROWTH
    7.4 BUBBLE-COLUMN SINGLE-USE BIOREACTORS 
           7.4.1 EFFICIENT MASS AND HEAT TRANSFER CAPABILITY TO DRIVE GROWTH
    7.5 OTHER SINGLE-USE BIOREACTORS 
 
8 SINGLE USE BIOREACTORS MARKET, BY MOLECULE TYPE (Page No. - 163)
    8.1 INTRODUCTION 
    8.2 MONOCLONAL ANTIBODIES 
           8.2.1 GROWING FOCUS ON THERAPEUTIC APPLICATIONS TO DRIVE DEMAND FOR SINGLE-USE BIOREACTORS
    8.3 VACCINES 
           8.3.1 USE OF SINGLE-USE SYSTEMS FOR VACCINE PRODUCTION TO BOOST MARKET GROWTH
    8.4 THERAPEUTIC PROTEINS & PEPTIDES 
           8.4.1 ABILITY OF SINGLE-USE TECHNOLOGIES TO HELP MINIMIZE CROSS-CONTAMINATION RISK TO BOOST ADOPTION
    8.5 STEM CELLS 
           8.5.1 GROWING RESEARCH AND COMMERCIALIZATION OF STEM CELL THERAPIES TO DRIVE MARKET
    8.6 CELL & GENE THERAPY 
           8.6.1 INCREASING RESEARCH INITIATIVES FOR GENE AND CELL THERAPIES TO DRIVE MARKET
 
9 SINGLE USE BIOREACTORS MARKET, BY CELL TYPE (Page No. - 182)
    9.1 INTRODUCTION 
    9.2 MAMMALIAN CELLS 
           9.2.1 GROWING USE OF MAMMALIAN CELLS IN PRODUCTION OF MONOCLONAL ANTIBODIES TO DRIVE MARKET
    9.3 BACTERIAL CELLS 
           9.3.1 GROWING ADOPTION IN COMMERCIAL VACCINES AND RECOMBINANT PROTEIN PRODUCTION TO DRIVE MARKET
    9.4 YEAST CELLS 
           9.4.1 HIGH GROWTH RATE AND MINIMAL MEDIA CONDITIONS TO DRIVE ADOPTION IN RECOMBINANT PROTEIN PRODUCTION
    9.5 OTHER CELLS 
 
10 SINGLE USE BIOREACTORS MARKET, BY APPLICATION (Page No. - 196)
     10.1 INTRODUCTION 
     10.2 BIOPRODUCTION 
             10.2.1 INCREASING BIOPHARMACEUTICAL PRODUCTION TO DRIVE DEMAND FOR COST-EFFECTIVE SINGLE-USE BIOREACTORS
     10.3 PROCESS DEVELOPMENT 
             10.3.1 ACCELERATED TIME-TO-MARKET TO PROPEL ADOPTION
     10.4 RESEARCH & DEVELOPMENT 
             10.4.1 RISING ADOPTION OF SINGLE-USE BIOREACTORS FOR COST-EFFECTIVENESS TO DRIVE MARKET
 
11 SINGLE USE BIOREACTORS MARKET, BY END USER (Page No. - 210)
     11.1 INTRODUCTION 
     11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 
             11.2.1 GROWING BIOLOGICS AND BIOSIMILARS MARKET TO INCREASE DEMAND FOR SINGLE-USE BIOREACTORS
     11.3 CONTRACT RESEARCH ORGANIZATIONS & CONTRACT MANUFACTURING ORGANIZATIONS 
             11.3.1 INCREASING OUTSOURCING OF R&D AND MANUFACTURING TO SUPPORT MARKET GROWTH
     11.4 ACADEMIC & RESEARCH INSTITUTES 
             11.4.1 COLLABORATIONS BETWEEN PHARMACEUTICAL & BIOPHARMACEUTICAL MANUFACTURERS AND RESEARCH INSTITUTES TO DRIVE MARKET
 
12 SINGLE USE BIOREACTORS MARKET, BY REGION (Page No. - 222)
     12.1 INTRODUCTION 
     12.2 NORTH AMERICA 
             12.2.1 US
                        12.2.1.1 US to dominate North American market during study period
             12.2.2 CANADA
                        12.2.2.1 Increasing government support for biologics manufacturing and rising research funding to propel market growth
     12.3 EUROPE 
             12.3.1 GERMANY
                        12.3.1.1 High government R&D investment and technological advancements to aid market growth
             12.3.2 UK
                        12.3.2.1 Increased government funding for pharmaceutical & biotechnology research to boost market growth
             12.3.3 FRANCE
                        12.3.3.1 Favorable government initiatives and increased investments by foreign pharmaceutical companies to augment market growth
             12.3.4 ITALY
                        12.3.4.1 Increasing government grants for biopharmaceutical and life science research to support market
             12.3.5 SPAIN
                        12.3.5.1 Rising focus on personalized medicine to fuel market growth
             12.3.6 REST OF EUROPE
     12.4 ASIA PACIFIC 
             12.4.1 CHINA
                        12.4.1.1 Low manufacturing costs and high investments in biotechnology sector to spur market growth
             12.4.2 SOUTH KOREA
                        12.4.2.1 Increased focus on quality manufacturing practices to aid market growth
             12.4.3 JAPAN
                        12.4.3.1 Increasing collaborations among biotechnology companies to drive market
             12.4.4 INDIA
                        12.4.4.1 High foreign direct investments and favorable government policies to propel market growth
             12.4.5 AUSTRALIA
                        12.4.5.1 Increased demand for innovative research solutions and developed pharmaceutical industry to support market growth
             12.4.6 REST OF ASIA PACIFIC
     12.5 LATIN AMERICA 
             12.5.1 BRAZIL
                        12.5.1.1 Increasing pharmaceutical R&D to fuel market growth
             12.5.2 MEXICO
                        12.5.2.1 Increased foreign direct investment from US and reduced pharmaceutical manufacturing costs to boost market growth
             12.5.3 REST OF LATIN AMERICA
     12.6 MIDDLE EAST 
             12.6.1 GCC COUNTRIES
                        12.6.1.1 Saudi Arabia
                                     12.6.1.1.1 Rising healthcare expenditure to boost market growth
                        12.6.1.2 UAE
                                     12.6.1.2.1 Increasing collaborations among biopharma companies to aid market growth
                        12.6.1.3 Rest of GCC countries
             12.6.2 REST OF MIDDLE EAST
     12.7 AFRICA 
             12.7.1 INCREASING DEMAND FOR DRUGS AND GROWING PATIENT POOL TO PROPEL MARKET GROWTH
 
13 COMPETITIVE LANDSCAPE (Page No. - 338)
     13.1 OVERVIEW 
     13.2 KEY PLAYER STRATEGY/RIGHT TO WIN 
             13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN SINGLE USE BIOREACTORS MARKET
     13.3 REVENUE ANALYSIS 
     13.4 MARKET SHARE ANALYSIS 
     13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 
             13.5.1 STARS
             13.5.2 EMERGING LEADERS
             13.5.3 PERVASIVE PLAYERS
             13.5.4 PARTICIPANTS
             13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
                        13.5.5.1 Company footprint
                        13.5.5.2 Region footprint
                        13.5.5.3 Product footprint
                        13.5.5.4 Application footprint
                        13.5.5.5 End-user footprint
     13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 
             13.6.1 PROGRESSIVE COMPANIES
             13.6.2 RESPONSIVE COMPANIES
             13.6.3 DYNAMIC COMPANIES
             13.6.4 STARTING BLOCKS
             13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
     13.7 COMPANY VALUATION AND FINANCIAL METRICS 
             13.7.1 FINANCIAL METRICS
             13.7.2 COMPANY VALUATION
     13.8 BRAND/PRODUCT COMPARISON 
     13.9 COMPETITIVE SCENARIO 
             13.9.1 PRODUCT LAUNCHES
             13.9.2 DEALS
             13.9.3 EXPANSIONS
 
14 COMPANY PROFILES (Page No. - 359)
     14.1 KEY PLAYERS 
             14.1.1 SARTORIUS AG
                        14.1.1.1 Business overview
                        14.1.1.2 Products offered
                        14.1.1.3 Recent developments
                                     14.1.1.3.1 Product launches
                                     14.1.1.3.2 Deals
                                     14.1.1.3.3 Expansions
                        14.1.1.4 MnM view
                                     14.1.1.4.1 Key strengths
                                     14.1.1.4.2 Strategic choices
                                     14.1.1.4.3 Weaknesses and competitive threats
             14.1.2 DANAHER CORPORATION
                        14.1.2.1 Business overview
                        14.1.2.2 Products offered
                        14.1.2.3 Recent developments
                                     14.1.2.3.1 Deals
                                     14.1.2.3.2 Expansions
                        14.1.2.4 MnM view
                                     14.1.2.4.1 Right to win
                                     14.1.2.4.2 Strategic choices
                                     14.1.2.4.3 Weaknesses and competitive threats
             14.1.3 THERMO FISHER SCIENTIFIC INC.
                        14.1.3.1 Business overview
                        14.1.3.2 Products offered
                        14.1.3.3 Recent developments
                                     14.1.3.3.1 Deals
                                     14.1.3.3.2 Expansions
                        14.1.3.4 MnM view
                                     14.1.3.4.1 Right to win
                                     14.1.3.4.2 Strategic choices
                                     14.1.3.4.3 Weaknesses and competitive threats
             14.1.4 MERCK KGAA
                        14.1.4.1 Business overview
                        14.1.4.2 Products offered
                        14.1.4.3 Recent developments
                                     14.1.4.3.1 Product launches
                                     14.1.4.3.2 Deals
                                     14.1.4.3.3 Expansions
                        14.1.4.4 MnM view
                                     14.1.4.4.1 Right to win
                                     14.1.4.4.2 Strategic choices
                                     14.1.4.4.3 Weaknesses and competitive threats
             14.1.5 AVANTOR, INC.
                        14.1.5.1 Business overview
                        14.1.5.2 Products offered
                        14.1.5.3 Recent developments
                                     14.1.5.3.1 Deals
                                     14.1.5.3.2 Expansions
             14.1.6 REPLIGEN CORPORATION
                        14.1.6.1 Business overview
                        14.1.6.2 Products offered
                        14.1.6.3 Recent developments
                                     14.1.6.3.1 Deals
                                     14.1.6.3.2 Expansions
             14.1.7 GETINGE AB
                        14.1.7.1 Business overview
                        14.1.7.2 Products offered
                        14.1.7.3 Recent developments
                                     14.1.7.3.1 Product launches
                                     14.1.7.3.2 Deals
                                     14.1.7.3.3 Expansions
             14.1.8 EPPENDORF SE
                        14.1.8.1 Business overview
                        14.1.8.2 Products offered
                        14.1.8.3 Recent developments
                                     14.1.8.3.1 Product launches
             14.1.9 PARKER HANNIFIN CORPORATION
                        14.1.9.1 Business overview
                        14.1.9.2 Products offered
             14.1.10 ENTEGRIS
                        14.1.10.1 Business overview
                        14.1.10.2 Products offered
                        14.1.10.3 Recent developments
                                     14.1.10.3.1 Expansions
             14.1.11 SAINT-GOBAIN
                        14.1.11.1 Business overview
                        14.1.11.2 Products offered
                        14.1.11.3 Recent developments
                                     14.1.11.3.1 Deals
                                     14.1.11.3.2 Expansions
             14.1.12 CORNING INCORPORATED
                        14.1.12.1 Business overview
                        14.1.12.2 Products offered
             14.1.13 LONZA
                        14.1.13.1 Business overview
                        14.1.13.2 Products offered
             14.1.14 TECNIC BIOPROCESS EQUIPMENT MANUFACTURING
                        14.1.14.1 Business overview
                        14.1.14.2 Products offered
                        14.1.14.3 Recent developments
                                     14.1.14.3.1 Product launches
                                     14.1.14.3.2 Deals
                                     14.1.14.3.3 Expansions
             14.1.15 FUJIMORI KOGYO CO., LTD.
                        14.1.15.1 Business overview
                        14.1.15.2 Products offered
                        14.1.15.3 Recent developments
                                     14.1.15.3.1 Expansions
     14.2 OTHER PLAYERS 
             14.2.1 KÜHNER AG
             14.2.2 OMNIBRX BIOTECHNOLOGIES
             14.2.3 NEW HORIZON BIOTECHNOLOGY, INC.
             14.2.4 PBS BIOTECH, INC.
             14.2.5 BBI-BIOTECH GMBH
             14.2.6 ABEC, INC.
             14.2.7 ESCO LIFESCIENCES GROUP LTD.
             14.2.8 DISTEK, INC.
             14.2.9 SATAKE MULTIMIX CORPORATION
             14.2.10 CELL CULTURE COMPANY, LLC
             14.2.11 MICRO DIGITAL CO., LTD.
             14.2.12 CELLTAINER BIOTECH B.V.
             14.2.13 MEISSNER FILTRATION PRODUCTS, INC.
             14.2.14 SOLIDA BIOTECH GMBH
             14.2.15 G&G TECHNOLOGIES, INC.
             14.2.16 PHARMNXT BIOTECH
             14.2.17 TOFFLON LIFE SCIENCE CO., LTD.
             14.2.18 SHANGHAI LEPURE BIOTECH CO., LTD.
 
15 APPENDIX (Page No. - 434)
     15.1 DISCUSSION GUIDE 
     15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     15.3 CUSTOMIZATION OPTIONS 
     15.4 RELATED REPORTS 
     15.5 AUTHOR DETAILS 
 
 
LIST OF TABLES (572 TABLES)
 
TABLE 1 SINGLE USE BIOREACTORS MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
TABLE 3 SINGLE USE BIOREACTORS INDUSTRY: RISK ASSESSMENT ANALYSIS
TABLE 4 MARKET: IMPACT ANALYSIS
TABLE 5 COMPARISON OF SINGLE-USE AND MULTIUSE BIOREACTORS
TABLE 6 WATER AND ENERGY CONSUMPTION FOR A TYPICAL PROCESS (COMMERCIAL MAB PRODUCTION AT 3 X 2,000 L SCALE)
TABLE 7 EXAMPLES OF ORGANIZATIONS INVOLVED IN SU STANDARDS
TABLE 8 COMPARISON OF SINGLE-USE BIOPROCESS SYSTEM DISPOSAL OPTIONS
TABLE 9 INDICATIVE PRODUCT PRICING ANALYSIS, BY KEY PLAYERS, 2023
TABLE 10 INDICATIVE PRICING ANALYSIS OF SINGLE-USE BIOREACTORS, BY REGION, 2023
TABLE 11 MARKET: RAW MATERIAL SUPPLIERS
TABLE 12 MARKET: MANUFACTURERS
TABLE 13 MARKET: END USERS
TABLE 14 MARKET: REGULATORY BODIES
TABLE 15 SINGLE-USE BIOREACTORS: COMPLEMENTARY TECHNOLOGIES
TABLE 16 SINGLE-USE BIOREACTORS: ADJACENT TECHNOLOGIES
TABLE 17 KEY PATENTS IN MARKET
TABLE 18 MARKET: CONFERENCES AND EVENTS, 2024–2025
TABLE 19 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 24 MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 25 KEY BUYING CRITERIA FOR SINGLE-USE BIOREACTORS, BY END USER
TABLE 26 IMPORT VALUE FOR HS CODE 841989, 2019–2023 (USD THOUSAND)
TABLE 27 EXPORT VALUE FOR HS CODE 841989, 2019–2023 (USD THOUSAND)
TABLE 28 IMPORT VOLUME FOR HS CODE 841989, 2019–2023 (TONS)
TABLE 29 EXPORT VOLUME FOR HS CODE 841989, 2019–2023 (TONS)
TABLE 30 SINGLE USE BIOREACTORS INDUSTRY, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 31 EXAMPLES OF SINGLE-USE BIOREACTOR SYSTEMS OFFERED BY MARKET PLAYERS
TABLE 32 SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2022–2029 (USD MILLION)
TABLE 33 SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 34 NORTH AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 35 EUROPE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 36 ASIA PACIFIC: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 37 LATIN AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 38 MIDDLE EAST: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 39 GCC COUNTRIES: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 40 ≤10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 41 NORTH AMERICA: ≤10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 42 EUROPE: ≤10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 43 ASIA PACIFIC: ≤10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 44 LATIN AMERICA: ≤10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 45 MIDDLE EAST: ≤10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 46 GCC COUNTRIES: ≤10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 47 11–100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 48 NORTH AMERICA: 11–100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 49 EUROPE: 11–100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 50 ASIA PACIFIC: 11–100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 51 LATIN AMERICA: 11–100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 52 MIDDLE EAST: 11–100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 53 GCC COUNTRIES: 11–100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 54 101–500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 55 NORTH AMERICA: 101–500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 56 EUROPE: 101–500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 57 ASIA PACIFIC: 101–500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 58 LATIN AMERICA: 101–500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 59 MIDDLE EAST: 101–500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 60 GCC COUNTRIES: 101–500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 61 501–1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 62 NORTH AMERICA: 501–1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 63 EUROPE: 501–1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 64 ASIA PACIFIC: 501–1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 65 LATIN AMERICA: 501–1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET,  BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 66 MIDDLE EAST: 501–1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 67 GCC COUNTRIES: 501–1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 68 >1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 69 NORTH AMERICA: >1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 70 EUROPE: >1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 71 ASIA PACIFIC: >1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 72 LATIN AMERICA: >1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 73 MIDDLE EAST: >1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 74 GCC COUNTRIES: >1500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 75 SINGLE-USE MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 76 SINGLE-USE MEDIA BAGS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 77 NORTH AMERICA: SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 78 EUROPE: SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 79 ASIA PACIFIC: SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 80 LATIN AMERICA: SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 81 MIDDLE EAST: SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 82 GCC COUNTRIES: SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 83 2D SINGLE-USE MEDIA BAGS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 84 NORTH AMERICA: 2D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 85 EUROPE: 2D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 86 ASIA PACIFIC: 2D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 87 LATIN AMERICA: 2D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 88 MIDDLE EAST: 2D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 89 GCC COUNTRIES: 2D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 90 3D SINGLE-USE MEDIA BAGS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 91 NORTH AMERICA: 3D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 92 EUROPE: 3D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 93 ASIA PACIFIC: 3D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 94 LATIN AMERICA: 3D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 95 MIDDLE EAST: 3D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 96 GCC COUNTRIES: 3D SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 97 OTHER SINGLE-USE MEDIA BAGS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 98 NORTH AMERICA: OTHER SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 99 EUROPE: OTHER SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 100 ASIA PACIFIC: OTHER SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 101 LATIN AMERICA: OTHER SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 102 MIDDLE EAST: OTHER SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 103 GCC COUNTRIES: OTHER SINGLE-USE MEDIA BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 104 SINGLE-USE ASSEMBLIES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 105 NORTH AMERICA: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 106 EUROPE: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 107 ASIA PACIFIC: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 108 LATIN AMERICA: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 109 MIDDLE EAST: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 110 GCC COUNTRIES: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 111 OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 112 NORTH AMERICA: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 113 EUROPE: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 114 ASIA PACIFIC: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 115 LATIN AMERICA: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 116 MIDDLE EAST: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 117 GCC COUNTRIES: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 118 SINGLE USE BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 119 EXAMPLES OF SINGLE-USE STIRRED-TANK BIOREACTOR SYSTEMS FOR STEM CELL CULTURE
TABLE 120 STIRRED-TANK SINGLE USE BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 121 NORTH AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 122 EUROPE: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 123 ASIA PACIFIC: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 124 LATIN AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 125 MIDDLE EAST: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 126 GCC COUNTRIES: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 127 WAVE-INDUCED SINGLE USE BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 128 NORTH AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 129 EUROPE: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 130 ASIA PACIFIC: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 131 LATIN AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 132 MIDDLE EAST: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 133 GCC COUNTRIES: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 134 BUBBLE-COLUMN SINGLE USE BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 135 NORTH AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 136 EUROPE: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 137 ASIA PACIFIC: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 138 LATIN AMERICA: MARKET,  BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 139 MIDDLE EAST: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 140 GCC COUNTRIES: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 141 OTHER SINGLE USE BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 142 NORTH AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 143 EUROPE: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 144 ASIA PACIFIC: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 145 LATIN AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 146 MIDDLE EAST: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 147 GCC COUNTRIES: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 148 SINGLE USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
TABLE 149 SINGLE USE BIOREACTORS INDUSTRY FOR MONOCLONAL ANTIBODIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 150 NORTH AMERICA: MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 151 EUROPE: MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 152 ASIA PACIFIC: MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 153 LATIN AMERICA: MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 154 MIDDLE EAST: MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 155 GCC COUNTRIES: MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 156 MARKET FOR VACCINES, BY REGION, 2022–2029 (USD MILLION)
TABLE 157 NORTH AMERICA: MARKET FOR VACCINES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 158 EUROPE: MARKET FOR VACCINES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 159 ASIA PACIFIC: MARKET FOR VACCINES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 160 LATIN AMERICA: MARKET FOR VACCINES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 161 MIDDLE EAST: MARKET FOR VACCINES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 162 GCC COUNTRIES: MARKET FOR VACCINES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 163 MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY REGION, 2022–2029 (USD MILLION)
TABLE 164 NORTH AMERICA: MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 165 EUROPE: MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 166 ASIA PACIFIC: MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 167 LATIN AMERICA: MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 168 MIDDLE EAST: MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 169 GCC COUNTRIES: MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 170 MARKET FOR STEM CELLS, BY REGION, 2022–2029 (USD MILLION)
TABLE 171 NORTH AMERICA: MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 172 EUROPE: MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 173 ASIA PACIFIC: MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 174 LATIN AMERICA: MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 175 MIDDLE EAST: MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 176 GCC COUNTRIES: MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 177 SINGLE USE BIOREACTORS MARKET FOR CELL & GENE THERAPY, BY REGION, 2022–2029 (USD MILLION)
TABLE 178 NORTH AMERICA: SINGLE USE BIOREACTORS INDUSTRY FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 179 EUROPE: MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 180 ASIA PACIFIC: MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 181 LATIN AMERICA: MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 182 MIDDLE EAST: MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 183 GCC COUNTRIES: MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 184 SINGLE USE BIOREACTORS INDUSTRY, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 185 MARKET FOR MAMMALIAN CELLS, BY REGION, 2022–2029 (USD MILLION)
TABLE 186 NORTH AMERICA: MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 187 EUROPE: MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 188 ASIA PACIFIC: MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 189 LATIN AMERICA: MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 190 MIDDLE EAST: MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 191 GCC COUNTRIES: MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 192 MARKET FOR BACTERIAL CELLS, BY REGION, 2022–2029 (USD MILLION)
TABLE 193 NORTH AMERICA: MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 194 EUROPE: MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 195 ASIA PACIFIC: MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 196 LATIN AMERICA: MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 197 MIDDLE EAST: MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 198 GCC COUNTRIES: MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 199 MARKET FOR YEAST CELLS, BY REGION, 2022–2029 (USD MILLION)
TABLE 200 NORTH AMERICA: MARKET FOR YEAST CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 201 EUROPE: MARKET FOR YEAST CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 202 ASIA PACIFIC: MARKET FOR YEAST CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 203 LATIN AMERICA: MARKET FOR YEAST CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 204 MIDDLE EAST: MARKET FOR YEAST CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 205 GCC COUNTRIES: MARKET FOR YEAST CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 206 SINGLE USE BIOREACTORS MARKET FOR OTHER CELLS, BY REGION, 2022–2029 (USD MILLION)
TABLE 207 NORTH AMERICA: MARKET FOR OTHER CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 208 EUROPE: MARKET FOR OTHER CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 209 ASIA PACIFIC: MARKET FOR OTHER CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 210 LATIN AMERICA: MARKET FOR OTHER CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 211 MIDDLE EAST: MARKET FOR OTHER CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 212 GCC COUNTRIES: MARKET FOR OTHER CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 213 MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 214 US: NUMBER OF PRODUCTS GOING OFF-PATENT, 2023–2028
TABLE 215 MARKET FOR BIOPRODUCTION, BY REGION, 2022–2029 (USD MILLION)
TABLE 216 NORTH AMERICA: MARKET FOR BIOPRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 217 EUROPE: MARKET FOR BIOPRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 218 ASIA PACIFIC: MARKET FOR BIOPRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 219 LATIN AMERICA: MARKET FOR BIOPRODUCTION,  BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 220 MIDDLE EAST: MARKET FOR BIOPRODUCTION, BY REGION, 2022–2029 (USD MILLION)
TABLE 221 GCC COUNTRIES: MARKET FOR BIOPRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 222 MARKET FOR PROCESS DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION)
TABLE 223 NORTH AMERICA: MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 224 EUROPE: MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 225 ASIA PACIFIC: MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 226 LATIN AMERICA: MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 227 MIDDLE EAST: MARKET FOR PROCESS DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION)
TABLE 228 GCC COUNTRIES: MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 229 MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION)
TABLE 230 NORTH AMERICA: MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 231 EUROPE: MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 232 ASIA PACIFIC: MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 233 LATIN AMERICA: MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 234 MIDDLE EAST: MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION)
TABLE 235 GCC COUNTRIES: MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 236 SINGLE USE BIOREACTORS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 237 SINGLE USE BIOREACTORS INDUSTRY FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 238 NORTH AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 239 EUROPE: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 240 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 241 LATIN AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 242 MIDDLE EAST: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 243 GCC COUNTRIES: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 244 MARKET FOR CROS & CMOS, BY REGION, 2022–2029 (USD MILLION)
TABLE 245 NORTH AMERICA: MARKET FOR CROS & CMOS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 246 EUROPE: MARKET FOR CROS & CMOS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 247 ASIA PACIFIC: MARKET FOR CROS & CMOS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 248 LATIN AMERICA: MARKET FOR CROS & CMOS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 249 MIDDLE EAST: MARKET FOR CROS & CMOS, BY REGION, 2022–2029 (USD MILLION)
TABLE 250 GCC COUNTRIES: MARKET FOR CROS & CMOS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 251 MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
TABLE 252 NORTH AMERICA: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 253 EUROPE: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 254 ASIA PACIFIC: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 255 LATIN AMERICA: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 256 MIDDLE EAST: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
TABLE 257 GCC COUNTRIES: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 258 SINGLE USE BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 259 NORTH AMERICA: SINGLE USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 260 NORTH AMERICA: MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 261 NORTH AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 262 NORTH AMERICA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 263 NORTH AMERICA: MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 264 NORTH AMERICA: MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
TABLE 265 NORTH AMERICA: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 266 NORTH AMERICA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 267 NORTH AMERICA: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 268 US: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 269 US: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 270 US: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 271 US: MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 272 US: MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
TABLE 273 US: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 274 US: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 275 US: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 276 CANADA: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 277 CANADA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 278 CANADA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 279 CANADA: MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 280 CANADA: MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
TABLE 281 CANADA: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 282 CANADA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 283 CANADA: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 284 EUROPE: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 285 EUROPE: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 286 EUROPE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 287 EUROPE: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 288 EUROPE: MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 289 EUROPE: MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
TABLE 290 EUROPE: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 291 EUROPE: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 292 EUROPE: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 293 GERMANY: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 294 GERMANY: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 295 GERMANY: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 296 GERMANY: MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 297 GERMANY: MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
TABLE 298 GERMANY: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 299 GERMANY: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 300 GERMANY: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 301 UK: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 302 UK: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 303 UK: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 304 UK: MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 305 UK: MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
TABLE 306 UK: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 307 UK: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 308 UK: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 309 FRANCE: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 310 FRANCE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 311 FRANCE: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 312 FRANCE: MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 313 FRANCE: MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
TABLE 314 FRANCE: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 315 FRANCE: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 316 FRANCE: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 317 ITALY: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 318 ITALY: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 319 ITALY: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 320 ITALY: MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 321 ITALY: MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
TABLE 322 ITALY: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 323 ITALY: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 324 ITALY: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 325 SPAIN: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 326 SPAIN: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 327 SPAIN: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 328 SPAIN: MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 329 SPAIN: MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
TABLE 330 SPAIN: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 331 SPAIN: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 332 SPAIN: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 333 REST OF EUROPE: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 334 REST OF EUROPE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 335 REST OF EUROPE: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 336 REST OF EUROPE: MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 337 REST OF EUROPE: MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
TABLE 338 REST OF EUROPE: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 339 REST OF EUROPE: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 340 REST OF EUROPE: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 341 ASIA PACIFIC: SINGLE USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 342 ASIA PACIFIC: MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 343 ASIA PACIFIC: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 344 ASIA PACIFIC: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 345 ASIA PACIFIC: MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 346 ASIA PACIFIC: MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
TABLE 347 ASIA PACIFIC: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 348 ASIA PACIFIC: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 349 ASIA PACIFIC: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 350 CHINA: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 351 CHINA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 352 CHINA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 353 CHINA: MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 354 CHINA: MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
TABLE 355 CHINA: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 356 CHINA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 357 CHINA: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 358 SOUTH KOREA: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 359 SOUTH KOREA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 360 SOUTH KOREA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 361 SOUTH KOREA: MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 362 SOUTH KOREA: MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
TABLE 363 SOUTH KOREA: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 364 SOUTH KOREA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 365 SOUTH KOREA: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 366 JAPAN: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 367 JAPAN: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 368 JAPAN: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 369 JAPAN: MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 370 JAPAN: MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
TABLE 371 JAPAN: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 372 JAPAN: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 373 JAPAN: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 374 INDIA: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 375 INDIA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 376 INDIA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 377 INDIA: MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 378 INDIA: MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
TABLE 379 INDIA: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 380 INDIA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 381 INDIA: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 382 AUSTRALIA: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 383 AUSTRALIA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 384 AUSTRALIA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 385 AUSTRALIA: MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 386 AUSTRALIA: MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
TABLE 387 AUSTRALIA: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 388 AUSTRALIA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 389 AUSTRALIA: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 390 REST OF ASIA PACIFIC: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 391 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 392 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 393 REST OF ASIA PACIFIC: MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 394 REST OF ASIA PACIFIC: MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
TABLE 395 REST OF ASIA PACIFIC: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 396 REST OF ASIA PACIFIC: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 397 REST OF ASIA PACIFIC: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 398 LATIN AMERICA: SINGLE USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 399 LATIN AMERICA: MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 400 LATIN AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 401 LATIN AMERICA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 402 LATIN AMERICA: MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 403 LATIN AMERICA: MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
TABLE 404 LATIN AMERICA: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 405 LATIN AMERICA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 406 LATIN AMERICA: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 407 BRAZIL: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 408 BRAZIL: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 409 BRAZIL: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 410 BRAZIL: MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 411 BRAZIL: MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
TABLE 412 BRAZIL: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 413 BRAZIL: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 414 BRAZIL: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 415 MEXICO: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 416 MEXICO: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 417 MEXICO: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 418 MEXICO: MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 419 MEXICO: MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
TABLE 420 MEXICO: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 421 MEXICO: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 422 MEXICO: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 423 REST OF LATIN AMERICA: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 424 REST OF LATIN AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 425 REST OF LATIN AMERICA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 426 REST OF LATIN AMERICA: MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 427 REST OF LATIN AMERICA: MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
TABLE 428 REST OF LATIN AMERICA: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 429 REST OF LATIN AMERICA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 430 REST OF LATIN AMERICA: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 431 MIDDLE EAST: SINGLE USE BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 432 MIDDLE EAST: MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 433 MIDDLE EAST: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 434 MIDDLE EAST: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 435 MIDDLE EAST: MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 436 MIDDLE EAST: MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
TABLE 437 MIDDLE EAST: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 438 MIDDLE EAST: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 439 MIDDLE EAST: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 440 GCC COUNTRIES: SINGLE USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 441 GCC COUNTRIES: MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 442 GCC COUNTRIES: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 443 GCC COUNTRIES: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 444 GCC COUNTRIES: MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 445 GCC COUNTRIES: MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
TABLE 446 GCC COUNTRIES: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 447 GCC COUNTRIES: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 448 GCC COUNTRIES: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 449 SAUDI ARABIA: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 450 SAUDI ARABIA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 451 SAUDI ARABIA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 452 SAUDI ARABIA: MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 453 SAUDI ARABIA: MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
TABLE 454 SAUDI ARABIA: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 455 SAUDI ARABIA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 456 SAUDI ARABIA: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 457 UAE: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 458 UAE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 459 UAE: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 460 UAE: MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 461 UAE: MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
TABLE 462 UAE: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 463 UAE: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 464 UAE: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 465 REST OF GCC COUNTRIES: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 466 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 467 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 468 REST OF GCC COUNTRIES: MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 469 REST OF GCC COUNTRIES: MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
TABLE 470 REST OF GCC COUNTRIES: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 471 REST OF GCC COUNTRIES: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 472 REST OF GCC COUNTRIES: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 473 REST OF MIDDLE EAST: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 474 REST OF MIDDLE EAST: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 475 REST OF MIDDLE EAST: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 476 REST OF MIDDLE EAST: MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 477 REST OF MIDDLE EAST: MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
TABLE 478 REST OF MIDDLE EAST: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 479 REST OF MIDDLE EAST: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 480 REST OF MIDDLE EAST: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 481 AFRICA: SINGLE USE BIOREACTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 482 AFRICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 483 AFRICA: SINGLE-USE BIOREACTOR MEDIA BAGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 484 AFRICA: MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 485 AFRICA: MARKET, BY MOLECULE TYPE, 2022–2029 (USD MILLION)
TABLE 486 AFRICA: MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 487 AFRICA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 488 AFRICA: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 489 OVERVIEW OF STRATEGIES ADOPTED BY KEY MANUFACTURING COMPANIES, 2021−2024
TABLE 490 SINGLE USE BIOREACTORS MARKET: DEGREE OF COMPETITION
TABLE 491 SINGLE USE BIOREACTORS INDUSTRY: REGION FOOTPRINT
TABLE 492 MARKET: PRODUCT FOOTPRINT
TABLE 493 MARKET: APPLICATION FOOTPRINT
TABLE 494 MARKET: END-USER FOOTPRINT
TABLE 495 MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 496 MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
TABLE 497 MARKET: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
TABLE 498 MARKET: DEALS, JANUARY 2021–JUNE 2024
TABLE 499 MARKET: EXPANSIONS, JANUARY 2021–JUNE 2024
TABLE 500 SARTORIUS AG: COMPANY OVERVIEW
TABLE 501 SARTORIUS AG: PRODUCTS OFFERED
TABLE 502 SARTORIUS AG: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
TABLE 503 SARTORIUS AG: DEALS, JANUARY 2021–JUNE 2024
TABLE 504 SARTORIUS AG: EXPANSIONS, JANUARY 2021–JUNE 2024
TABLE 505 DANAHER CORPORATION: COMPANY OVERVIEW
TABLE 506 DANAHER CORPORATION: PRODUCTS OFFERED
TABLE 507 DANAHER CORPORATION: DEALS, JANUARY 2021–JUNE 2024
TABLE 508 DANAHER CORPORATION: EXPANSIONS, JANUARY 2021–JUNE 2024
TABLE 509 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 510 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
TABLE 511 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–JUNE 2024
TABLE 512 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021–JUNE 2024
TABLE 513 MERCK KGAA: COMPANY OVERVIEW
TABLE 514 MERCK KGAA: PRODUCTS OFFERED
TABLE 515 MERCK KGAA: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
TABLE 516 MERCK KGAA: DEALS, JANUARY 2021–JUNE 2024
TABLE 517 MERCK KGAA: EXPANSIONS, JANUARY 2021–JUNE 2024
TABLE 518 AVANTOR, INC.: COMPANY OVERVIEW
TABLE 519 AVANTOR, INC.: PRODUCTS OFFERED
TABLE 520 AVANTOR, INC.: DEALS, JANUARY 2021–JUNE 2024
TABLE 521 AVANTOR, INC.: EXPANSIONS, JANUARY 2021–JUNE 2024
TABLE 522 REPLIGEN CORPORATION: COMPANY OVERVIEW
TABLE 523 REPLIGEN CORPORATION: PRODUCTS OFFERED
TABLE 524 REPLIGEN CORPORATION: DEALS, JANUARY 2021–JUNE 2024
TABLE 525 REPLIGEN CORPORATION: EXPANSION, JANUARY 2021–JUNE 2024
TABLE 526 GETINGE AB: COMPANY OVERVIEW
TABLE 527 GETINGE AB: PRODUCTS OFFERED
TABLE 528 GETINGE AB: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
TABLE 529 GETINGE AB: DEALS, JANUARY 2021–JUNE 2024
TABLE 530 GETINGE AB: EXPANSIONS, JANUARY 2021–JUNE 2024
TABLE 531 EPPENDORF SE: COMPANY OVERVIEW
TABLE 532 EPPENDORF SE: PRODUCTS OFFERED
TABLE 533 EPPENDORF SE: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
TABLE 534 PARKER HANNIFIN CORPORATION: COMPANY OVERVIEW
TABLE 535 PARKER HANNIFIN CORPORATION: PRODUCTS OFFERED
TABLE 536 ENTEGRIS: COMPANY OVERVIEW
TABLE 537 ENTEGRIS: PRODUCTS OFFERED
TABLE 538 ENTEGRIS: EXPANSION, JANUARY 2021–JUNE 2024
TABLE 539 SAINT-GOBAIN: COMPANY OVERVIEW
TABLE 540 SAINT-GOBAIN: PRODUCTS OFFERED
TABLE 541 SAINT-GOBAIN: DEALS, JANUARY 2021–JUNE 2024
TABLE 542 SAINT-GOBAIN: EXPANSIONS, JANUARY 2021–JUNE 2024
TABLE 543 CORNING INCORPORATED: COMPANY OVERVIEW
TABLE 544 CORNING INCORPORATED: PRODUCTS OFFERED
TABLE 545 LONZA: COMPANY OVERVIEW
TABLE 546 LONZA: PRODUCTS OFFERED
TABLE 547 TECNIC BIOPROCESS EQUIPMENT MANUFACTURING: COMPANY OVERVIEW
TABLE 548 TECNIC BIOPROCESS EQUIPMENT MANUFACTURING: PRODUCTS OFFERED
TABLE 549 TECNIC BIOPROCESS EQUIPMENT MANUFACTURING: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
TABLE 550 TECNIC BIOPROCESS EQUIPMENT MANUFACTURING: DEALS, JANUARY 2021–JUNE 2024
TABLE 551 TECNIC BIOPROCESS EQUIPMENT MANUFACTURING: EXPANSIONS, JANUARY 2021–JUNE 2024
TABLE 552 FUJIMORI KOGYO CO., LTD.: COMPANY OVERVIEW
TABLE 553 FUJIMORI KOGYO CO., LTD.: PRODUCTS OFFERED
TABLE 554 FUJIMORI KOGYO CO., LTD.: EXPANSIONS, JANUARY 2021–JUNE 2024
TABLE 555 KUHNER AG: COMPANY OVERVIEW
TABLE 556 OMNIBRX BIOTECHNOLOGIES: COMPANY OVERVIEW
TABLE 557 NEW HORIZON BIOTECHNOLOGY, INC.: COMPANY OVERVIEW
TABLE 558 PBS BIOTECH, INC.: COMPANY OVERVIEW
TABLE 559 BBI-BIOTECH GMBH: COMPANY OVERVIEW
TABLE 560 ABEC, INC.: COMPANY OVERVIEW
TABLE 561 ESCO LIFESCIENCES GROUP LTD.: COMPANY OVERVIEW
TABLE 562 DISTEK, INC.: COMPANY OVERVIEW
TABLE 563 SATAKE MULTIMIX CORPORATION: COMPANY OVERVIEW
TABLE 564 CELL CULTURE COMPANY, LLC: COMPANY OVERVIEW
TABLE 565 MICRO DIGITAL CO., LTD.: COMPANY OVERVIEW
TABLE 566 CELLTAINER BIOTECH B.V.: COMPANY OVERVIEW
TABLE 567 MEISSNER FILTRATION PRODUCTS, INC.: COMPANY OVERVIEW
TABLE 568 SOLIDA BIOTECH GMBH: COMPANY OVERVIEW
TABLE 569 G&G TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 570 PHARMNXT BIOTECH: COMPANY OVERVIEW
TABLE 571 TOFFLON LIFE SCIENCE CO., LTD.: COMPANY OVERVIEW
TABLE 572 SHANGHAI LEPURE BIOTECH CO., LTD.: COMPANY OVERVIEW
 
 
LIST OF FIGURES (58 FIGURES)
 
FIGURE 1 RESEARCH DESIGN
FIGURE 2 BREAKDOWN OF PRIMARIES: SINGLE USE BIOREACTORS MARKET
FIGURE 3 SINGLE USE BIOREACTORS INDUSTRY SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
FIGURE 4 GLOBAL MARKET SIZE ESTIMATION APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
FIGURE 5 ILLUSTRATIVE EXAMPLE OF SARTORIUS AG: REVENUE SHARE ANALYSIS (2023)
FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 8 SINGLE USE BIOREACTORS INDUSTRY: CAGR PROJECTIONS
FIGURE 9 DATA TRIANGULATION METHODOLOGY
FIGURE 10 SINGLE USE BIOREACTORS INDUSTRY, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
FIGURE 11 SINGLE USE BIOREACTORS INDUSTRY, BY TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 12 SINGLE USE BIOREACTORS INDUSTRY, BY MOLECULE TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 13 SINGLE USE BIOREACTORS INDUSTRY, BY CELL TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 14 SINGLE USE BIOREACTORS INDUSTRY, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 15 SINGLE USE BIOREACTORS INDUSTRY, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 16 GEOGRAPHIC SNAPSHOT OF SINGLE USE BIOREACTORS INDUSTRY
FIGURE 17 RISING DEMAND FOR BIOLOGICS AND ADVANTAGES OF SUBS OVER CONVENTIONAL BIOREACTORS ARE EXPECTED TO PROPEL MARKET
FIGURE 18 BIOPRODUCTION APPLICATION SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
FIGURE 19 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 20 CHINA PROJECTED TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 21 SINGLE USE BIOREACTORS INDUSTRY: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 22 ANNUAL PRODUCTION CAPACITY: SINGLE-PRODUCT FACILITY VS. MULTI-PRODUCT FACILITY
FIGURE 23 ANNUAL PRODUCTION CAPACITY: SINGLE-PRODUCT FACILITY VS. MULTI-PRODUCT FACILITY
FIGURE 24 BIOSIMILAR APPROVALS & LAUNCHES, 2015–2023
FIGURE 25 REVENUE SHIFTS IN SINGLE USE BIOREACTORS INDUSTRY
FIGURE 26 SINGLE USE BIOREACTORS INDUSTRY: SUPPLY CHAIN ANALYSIS
FIGURE 27 SINGLE USE BIOREACTORS INDUSTRY: VALUE CHAIN ANALYSIS
FIGURE 28 SINGLE USE BIOREACTORS INDUSTRY: ECOSYSTEM
FIGURE 29 NUMBER OF PATENTS GRANTED, 2014–2024
FIGURE 30 SINGLE USE BIOREACTORS INDUSTRY: PORTER’S FIVE FORCES ANALYSIS
FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SINGLE-USE BIOREACTORS PRODUCTS
FIGURE 32 KEY BUYING CRITERIA FOR SINGLE-USE BIOREACTORS AMONG END USERS
FIGURE 33 PHARMACEUTICAL R&D SPENDING, 2014–2028 (USD BILLION)
FIGURE 34 NORTH AMERICA: SINGLE USE BIOREACTORS INDUSTRY SNAPSHOT
FIGURE 35 US: FUNDING BY NATIONAL INSTITUTES OF HEALTH, 2014–2024
FIGURE 36 ASIA PACIFIC: SINGLE USE BIOREACTORS INDUSTRY SNAPSHOT
FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN SINGLE USE BIOREACTORS INDUSTRY, 2019–2023
FIGURE 38 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2023
FIGURE 39 SINGLE USE BIOREACTORS INDUSTRY: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
FIGURE 40 SINGLE USE BIOREACTORS INDUSTRY: COMPANY FOOTPRINT
FIGURE 41 SINGLE USE BIOREACTORS INDUSTRY: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
FIGURE 42 EV/EBITDA OF KEY VENDORS
FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 44 SINGLE USE BIOREACTORS MARKET: BRAND/PRODUCT COMPARISON
FIGURE 45 SARTORIUS AG: COMPANY SNAPSHOT (2023)
FIGURE 46 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 47 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
FIGURE 48 MERCK KGAA: COMPANY SNAPSHOT (2023)
FIGURE 49 AVANTOR, INC.: COMPANY SNAPSHOT (2023)
FIGURE 50 REPLIGEN CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 51 GETINGE AB: COMPANY SNAPSHOT (2023)
FIGURE 52 EPPENDORF SE: COMPANY SNAPSHOT (2023)
FIGURE 53 PARKER HANNIFIN CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 54 ENTEGRIS: COMPANY SNAPSHOT (2023)
FIGURE 55 SAINT-GOBAIN: COMPANY SNAPSHOT (2023)
FIGURE 56 CORNING INCORPORATED: COMPANY SNAPSHOT (2023)
FIGURE 57 LONZA: COMPANY SNAPSHOT (2023)
FIGURE 58 FUJIMORI KOGYO CO., LTD.: COMPANY SNAPSHOT (2023)

This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global single-use bioreactors market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single-use bioreactors market. The secondary sources used for this study include World Health Organization (WHO), National Institutes of Health (NIH), United States Food and Drug Administration (US FDA), National Institute for Bioreactors Research and Training (NIBRT), Society for Biological Engineering (SBE), Bio-Process Systems Alliance (BPSA), European Patent Office (EPO), Pharmaceuticals Export Promotion Council of India (Pharmexcil), India Brand Equity Foundation (IBEF), Biotechnology Innovation Organization (BIO), National Center for Biotechnology Information (NCBI), BioPharm International, EvaluatePharma, ScienceDirect, BioProcess International, Journal of Bioreactors and Biotechniques, BioPlan Associates, Eurostat, and Factiva, research journals; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global single-use bioreactors market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as pharmaceutical and biotechnology companies, CROs, CMOs, and academic & research institutes, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across six major regions, including the Asia Pacific, North America, Europe, Latin America, Middle East and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

Single-Use Bioreactors Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-use bioreactors market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Bottom-up Approach

  • The key players in the industry and market have been identified through extensive secondary research
  • The revenues generated from the single-use bioreactors business of leading players have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Single-Use Bioreactors Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Top-down Approach

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

Single-Use Bioreactors Market Size, and Share

Data Triangulation

After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Single-use bioreactors (SUBs) or disposable bioreactors are vessels that consist of a disposable bag instead of a typical culture vessel made of stainless steel or glass. SUBs are based on single-use technology, which uses disposable equipment to manufacture biopharmaceutical products. The key benefits of single-use bioreactor include reduced risk of cross-contamination, lower capital and operational costs, faster turnaround times, and greater flexibility in manufacturing. These advantages make single-use systems particularly attractive for the production of biologics, vaccines, and personalized medicines, where flexibility, speed, and sterility are paramount.

Stakeholders

  • Manufacturers of Single-use bioreactors and associated products
  • Distributors of Single-use bioreactors and associated products
  • Pharmaceutical and Biotechnology Companies
  • Contract Manufacturing Companies (CMOs)
  • Contract Research Organizations (CROs)
  • Academic and Research Institutes
  • Life Sciences Companies
  • Market Research and Consulting Firms
  • Venture Capitalists and Investors
  • Government Organizations
  • Medical Institutes and Universities
  • Private Research Firms

Report Objectives

  • To define, describe, and forecast the single use bioreactors market based on product, type, molecule type, cell type, application, end user, and region
  • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall single-use bioreactors market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to six main regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
  • To profile the key players in the single use bioreactors market and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments in the single use bioreactors market, such as acquisitions, product launches, expansions, agreements, partnerships, and collaborations
  • To benchmark players within the single use bioreactors market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business strategy and product strategy

1 Micro markets are the further segments and subsegments of the single use bioreactors market included in the report

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Portfolio Assessment

  • Product Matrix, which gives a detailed comparison of the product portfolios of the top three companies.

Company Information

  • Detailed analysis and profiling of additional market players (up to three).

Geographical Analysis

  • A further breakdown of the Rest of Asia Pacific single use bioreactors market into countries
  • A further breakdown of the Rest of European single use bioreactors market into countries
  • A further breakdown of the Rest of Latin American single use bioreactors market into countries
  • A further breakdown of the Rest of Middle East single use bioreactors market into countries
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
BT 2863
Published ON
Aug, 2024
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Single-use Bioreactors Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status
Website Feedback